A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate survival benefit of TS-1 plus cisplatin as a neoadjuvant
chemotherapy in gastric cancer patient with resectable type 4 (linitis plastica type) and
large type 3 tumor in comparison with surgery alone.